Coda Octopus Group, Inc. has appointed Mark Kelly as its new Chief Financial Officer, effective August 3, 2026, subject to a three-month probationary period. He succeeds retiring Interim CFO Gayle Jardine. Mr. Kelly brings finance experience from pharmaceutical and insurance companies, including Medac Pharma and Chubb Insurance. His compensation includes an annual base salary of £165,000 (approximately $218,625), discretionary bonuses, and a $40,000 restricted stock grant vesting over two years.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CODA OCTOPUS GROUP INC (CODA)?

Major stakeholders currently include Vanguard Capital Management LLC ($3.0M), Marshall Wace, LLP ($2.9M), Essex Investment Management Co LLC ($2.1M). Based on the latest 13F filings, there are a total of 64 tracked investment funds and institutions maintaining positions in CODA.

What is the overall institutional sentiment toward CODA recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $13.1M, driven by 43 managers accumulating shares while 20 reduced their exposure.

Which institutions have been selling or reducing their CODA positions?

In the latest period, 9 funds trimmed their holdings, and 11 managers completely exited their positions. The aggregate reported sell value was $6.5M.

Are there any notable investors adding CODA to their portfolios?

Yes, buying activity remains notable. 28 institutions opened new positions in {ticker}, and 15 existing holders added to their shares. The total reported buy value for the quarter amounted to $21.6M.